Marc Fellmann

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Disease Activity

Ulcerative Colitis

Atopic Dermatitis

Top Venues

Inflammatory bowel diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Vipul Jairath, David T Rubin, Bram Verstockt, Ayhan H Çekin, Maria T Abreu, Charlie W Lees, Marc Fellmann, John C Woolcott, Catherine Crosby, Joseph Wu, Abhishek Bhattacharjee, David Herman, Guibao Gu, Britta Siegmund
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program. Inflammatory bowel diseases (2024)
Peter Schmid-Grendlmeier, Melinda J Gooderham, Karin Hartmann, Konstantinou George, Marc Fellmann, Christopher Koulias, Claire Clibborn, Pinaki Biswas, Patrick M Brunner
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies. Allergy (2023)
Luc Biedermann, Marla C Dubinsky, Séverine Vermeire, Marc Fellmann, Sean Gardiner, Peter Hur, Rajiv Mundayat, Julian Panés, David T Rubin
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflammatory bowel diseases (2022)